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Abstract
Background: Understanding the prevalence and risk factors for common causes of ulcerative genital disease in the
general population would inform current STI syndromic management and HIV testing strategies in high HIV
prevalence regions of India.
Methods: Persons 15-49 years old from 32 rural and 34 urban clusters were sampled using a stratified random
method to represent adults in the high HIV prevalence Guntur district in Andhra Pradesh state. Interviews were
conducted and dry blood spots were collected on 12,617 study participants. Testing for HSV-2 and syphilis was
performed.
Results: Adjusted HSV-2 and syphilis seroprevalence rates were 4.70% and 2.08% for men and 7.07% and 1.42% for
women. For men, tattooing, >3 lifetime sex partners, tobacco use, and sex with men in the past 6 months were
associated with HSV-2 or syphilis (ORs, 1.66-2.95, p < 0.05). Male circumcision was positively associated with HSV-2
infection (OR, 1.37, p = 0.028) though this could be due to residual confounding. In women, greater than one
lifetime partner remained significantly associated with HSV-2 in multivariate analysis (OR, 2.61; 95% CI, 1.39-4.87).
Among all behavioral risk factors and other covariates in women and men, HIV infection exhibited the strongest
association with HSV-2 and syphilis (ORs, 8.2-14.2, p < 0.001). The proportion of individuals with HSV-2 who were
HIV infected was less than the proportion with syphilis who were HIV infected (11.8% vs. 22.7%; p = 0.001).
Conclusions: Nearly one in four persons surveyed in this population-based study that were seroprevalent for
syphilis, were also HIV infected. Common population risk factors for syphilis, HSV-2 and HIV and high rates of co-
seroprevalence suggest that HIV testing, STI testing and service strategies for these would benefit from direct
linkage in India.
Background
Reports from sexually transmitted disease clinics and
single health care institutions in India suggest an
increase in genital ulcerative sexually transmitted infec-
tions and decline in non-ulcerative sexually transmitted
infections [1,2]. Amongst sexually transmitted ulcerative
infections, Treponema pallidum, the bacterium causing
syphilis and herpes simplex virus type-2 (HSV-2) have
the highest prevalence [1] followed by chancroid and
donovanosis which are in decline [3]. HSV-2 seropreva-
lence rates in the general adult population in India have
been reported to range from 7.9 to 18.9% [4-6], translat-
ing into 100-200 million individuals who have acquired
HSV-2 infection. While HSV-2 can be a cause of
significant morbidity through genital ulcer disease, cen-
tral nervous system disease, and liver involvement, one
of the major reasons for interest in HSV-2 is because of
its strong association with HIV infection. Despite two
recent large randomized trials that demonstrated a lack
of an effect of pharmacologic herpes suppression in pre-
venting incident cases of HIV infection [7,8], the contin-
ued significant and strong epidemiological evidence
linking HIV to HSV-2 continues to support research
into novel strategies to mitigate new HIV infection in
those who are HSV-2 infected. Moreover, in a study in
the state of Karnataka in India, there was significant het-
erogeneity of HSV-2 infection with higher rates in rural
areas and amongst women [6].
The little information available on rates of syphilis in
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amongst a convenience sample of long-distance truck-
drivers in 2000 [4,5]. Syphilis has also been implicated
in increasing susceptibility to HIV infection [9], and
HIV prevention interventions based on syphilis and
other STI control have, except for in one isolated
instance [10], also led to disappointing results [11,12].
Additionally, spikes in syphilis infection has become a
concern in men who have sex with men (MSM) com-
munities in other settings [13]. However this has yet to
be reported from India, where MSM have one of the
highest rates of HIV prevalence amongst groups at high
risk of sexual transmission of HIV [14].
Thus HSV-2 and syphilis infection could have a great
impact on the Indian population. A better understand-
ing of population level data on the prevalence of HSV-2
and syphilis, and the risk factors for these two important
causes of genito-ulcerative diseases could improve public
health STI prevention efforts in the country and their
integration with HIV prevention efforts.
We report seroprevalence rates and potential risk fac-
tors for HSV-2 and syphilis from a population-based
study in Guntur district in the south Indian state of
Andhra Pradesh. This district and state have one of the
highest burdens of HIV infection due to sexual trans-
mission in India [14].
Methods
Study population and Setting
Overall 12,617 persons 15-49 years old from 32 rural and
34 urban clusters were sampled using a stratified random
method to represent adults in the Guntur district of
Andhra Pradesh (AP) India previously described in detail
elsewhere [15]. In brief, Guntur district, which had a
population of 4.5 million in the 2001 census with 29%
urban, was stratified into three regions with different
levels of development (literacy, assets, electricity and
water assets from census data), and rural and urban areas
selected that together would be representative of the dis-
trict. Within these areas, clusters of 1300-1600 popula-
tion were selected randomly, and systematic sampling
was done to select households in order to get 200-230
eligible persons aged 15-49 years in each cluster. All resi-
dents in this age group in each selected household were
considered eligible, with a resident defined as someone
who had lived in the selected area for the past 6 months
or more and a household defined as persons eating from
the same kitchen. Assuming a participation rate of 90%
o ft h ee l i g i b l ep e r s o n sb a s e d on pilot studies, we esti-
mated a final sample of about 12 400 persons with
approximately equal men-women and rural-urban distri-
bution [15]. Trained field investigators obtained written
informed consent from eligible people for participation
in the study prior to confidential interview and dry blood
spot sampling. As the blood test results would be
unlinked with the respondent identity, those interested in
knowing their HIV/STI status were referred to the near-
est public sector voluntary counselling and testing centre.
The protocols and procedures for this study were
approved by institutional ethics committees of the
Nizam’s Institute of Medical Sciences and the Adminis-
trative Staff College of India in Hyderabad, India.
Interviews
Confidential interviews were conducted between Sep-
tember of 2004 and September of 2005 with participants
to obtain socio-demographic information and other risk
factors that may be associated with the occurrence of
sexually transmitted infections [16]. Socio-demographic
information included age, sex, education, caste, and a
modified standard of living index which is based upon
living conditions and ownership of assets [17]. The caste
system is a social class system and categories were those
used by the Government of India and categorized from
highest to lowest: Forward Caste, Backwards Caste,
Scheduled Caste and Scheduled Tribe.
Information relevant to this paper included number of
lifetime sex partners, frequency of condom use, fre-
quency of alcohol use before sex, blood transfusion his-
tory, tattooing, use of recreational drugs, alcohol use,
tobacco use, and time spent away from home. For men,
female sex worker (FSW) history, having sex with men
and self reported circumcision status were obtained.
Blood samples
A validated finger prick method with a safety lancet was
used to take blood samples from each respondent for
dry blood spot (DBS) preparation on Whatman No. 3
paper (Whatman International Ltd, Maidstone, UK)
[18]. Testing was done using standard methods and kits
for detecting HSV-2 IgG (HerpeSelect 2 ELISA IgG,
Focus Diagnostics, CA) [19,20] and Treponema palli-
dum IgG (Treponostika sandwich ELISA, bioMérieux,
France). The DBS results for HSV-2 and syphilis
demonstrated 100% specificity and sensitivity when
compared to standard serum testing of 75 samples from
STD clinic patients and controls. All positive DBS sam-
ples were re-tested for confirmation and a 10% random
sample of negative samples was re-tested revealing
100% concordance with the initial result. Both tests
indicate lifetime prevalence of disease. Sequential HIV
1/2 antibody, Western blot, p24 antigen and pooled
nucleic acid tests from study participants were con-
ducted according to algorithms and methods described
elsewhere, [15] with “HIV” in this report referring to
HIV-1 and/or HIV-2 seroprevalence and/or acute HIV-
1 infection. HIV prevalence and risk factors in this
cohort have been described previously [15,21].
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The prevalence of HSV-2, syphilis, HSV-2/HIV co-pre-
valence and syphilis/HIV co-prevalence are reported.
We examined the relationship of HSV-2 and syphilis
seroprevalence with sociodemographic and risk variables
(hygiene, substance use, sexual risk, HIV, and STI) in
bivariate analyses for men and women separately. We
then utilized a stepwise approach by creating two sepa-
rate initial logistic regression models for HSV-2 and
syphilis which included either sociodemographic or risk
variables significant at the p < 0.05 level from bivariate
analyses. Variables from thes o c i o d e m o g r a p h i ca n dr i s k
models that remained statistically significant in the
initial regression analyses were then combined into one
final multiple logistic regression model for HSV-2 and
syphilis separately for men and women. HIV serostatus
was also examined as an outcome variable in separate
models including HSV-2, syphilis and significant risk
and sociodemographic variables. Data were analyzed
using STATA software version 9.0 (StataSoft Corp, Aus-
tin TX, USA).
Results
Of the final 13,838 15-49-year-olds sampled, 12,617
( 9 1 . 2 % )g a v eab l o o ds a m p l ea n di n t e r v i e w ,6 %d i dn o t
participate, and 2.8% provided an interview only. Of this
final analytic sample 12,617 study participants who pro-
vided a blood sample, 6317 (50.1%) were rural residents,
6382 (50.6%) were women, 4582 (36.3%) <25 years of
age, and 4310 (34.2%) had not had any schooling.
Seroprevalence
Population-based proportions of HSV-2 and syphilis for
the two sexes and urban and rural residence are pre-
sented in Table 1. The overall seroprevalence of HSV-2
and syphilis adjusted for the age, sex and rural-urban
distribution of Guntur district population was 5.87%
(95% CI, 4.28-7.46) and 1.75% (95% CI, 1.33-2.17),
respectively. HSV-2 and syphilis seroprevalence
increased with age, decreased with increasing education
and improved SLI, and was higher in urban residents.
These relationships were maintained when stratified by
gender. However, women were more likely to have
HSV-2 (OR, 1.54; 95% CI, 1.34 - 1.78) and less likely to
have syphilis (OR, 0.56; 95% CI, 0.42 - 0.74) when com-
pared to men adjusting for sociodemographic character-
istics that were included in the final model.
Risk Factors
In bivariate analyses, risk variables associated with HSV-
2 or syphilis in men included lack of toilet facility at
home, history of transfusion, tattooing, circumcision,
tobacco use, alcohol consumption, multiple lifetime
female partners, ever having had sex with female sex
workers, condom use, ever having had sex with men,
using alcohol before sex, HSV-2 or syphilis and HIV 1/2
seroprevalence. In women, history of having a toilet
facility at home, history of transfusion, any recreational
drug use, ever chewed tobacco, condom use, having had
more than one lifetime partner, HSV-2 or syphilis and
HIV status were associated with HSV-2 or syphilis sero-
prevalence. Variables that remained statistically signifi-
cant after separate initial multiple logistic regression
models for behavioral and sociodemographic variables
with outcome of HSV-2 and syphilis are combined into
final models for men (Table 2) and women (Table 3)
separately. The range of R
2 for final models was 0.14-
0.18.
In these final models, of all substance use related
items (tobacco use, drinking alcohol, use of alcohol
before sex, and use of other recreational drugs) for men,
none demonstrated a significant association with HSV-2
(ORs, 0.62-1.64; p values, 0.053-0.52) and only current
tobacco use was marginally associated with syphilis sero-
prevalence (OR, 2.07; 95% CI, 1.26-3.41). Men who
never used condoms had similar rates of HSV-2 and
syphilis to men who had never had sex or last sex was
more than 6 months prior to interview (ORs, 0.39-1.02;
p values, 0.059-0.96).
Variables that were associated with HSV-2 in women
and remained significant after multivariate modeling
included greater than one lifetime partner (OR, 2.61;
95% CI, 1.39-4.87), HIV (OR, 14.07; 95% CI, 8.84-22.40)
and syphilis (OR, 6.66; 95% CI, 3.88-11.42). Never using
a condom was negatively associated with HSV-2
amongst women who had ever had sex (OR, 0.69; 95%
CI, 0.53-0.91).
The relationship between circumcision and HSV-2 in
men was a bit more complicated as HSV-2 seropreva-
lence rates were higher in circumcised men in bivariate
analyses of all men (7.9% vs 5.3%; p = 0.002), sexually
active men (8.7% vs. 6.4%; p = 0.02) and sexually inac-
tive men (5.6% vs. 1.9%; p = 0.001). In multivariate ana-
lysis, male circumcision demonstrated a significant
association with HSV-2 (OR, 1.37; 95% CI, 1.03-1.82)
but not with syphilis (OR, 1.20; 95% CI, 0.77-1.66). Cir-
c u m c i s e dm e nw e r el i k e l yt oh a v em o r el i f e t i m es e x u a l
partners, including FSWs, than those who were not cir-
cumcised (8.6 partners vs. 5.0 partners; p = 0.007) and
were more likely to have had contact with a FSW
(35.5% vs. 22.7%; p < 0.001). When adding risk factors
significant in bivariate analyses sequentially to our final
HSV-2 model in Table 2, ever having contact with a
FSW decreased the point estimate of circumcision by
the greatest magnitude. Of the men in this study, 899
(14.4%) were Muslim of whom 96.4% reported being cir-
cumcised, whereas only 2.9% of the non-Muslim men
reported being circumcised. Religion was not used in
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male circumcision. The latter was included in the model
as it was expected to have a more direct relation with
sexually transmitted infections and it may be a risk fac-
tor that is modifiable in this setting.
Relationship of HIV seroprevalence with HSV-2 and
syphilis
Co-seroprevalence rates of HSV-2 or syphilis with HIV
infection and proportions of HSV-2 or syphilis infected
with HIV are presented in Table 4. The proportion of
HSV-2 individuals who were HIV infected was less when
compared to the proportion of syphilis individuals who
were HIV infected (11.8% vs. 22.7%; Chi-square 10.48; p =
0.001). HIV 1/2 seroprevalence had a strong association
with HSV-2 and syphilis in men (OR, 13.98; 95% CI 9.27-
21.10) and (OR, 8.58; 95% CI 4.93-14.92), respectively.
Discussion
This report examines HSV-2 and syphilis seroprevalence
and associated risk factors in a large population-based
sample, with a high participation rate, in a high HIV
prevalent district [22] within a high prevalence state
[14] of India. Seroprevalence of HSV-2 and syphilis
demonstrated rural urban and gender differences. Sero-
prevalence for both HSV-2 and syphilis was higher in
urban areas, HSV-2 was higher amongst women and
syphilis was slightly higher in men.
Though less information from population based stu-
dies exists on rates of syphilis infection, estimates sug-
gest that South Asia has the highest number of cases in
the world [23]. Moreover, the burden of HSV-2 and
syphilis infection extrapolated from these rates is high
and supports current national efforts to address STI dis-
ease in the country. In general terms while the overall
prevalence of HSV-2 is significantly lower than many
other countries in sub-Saharan Africa, the ratio of HSV-
2/HIV seroprevalence at 2-3 is roughly similar between
our study and HSV-2/HIV seroprevalence ratios found
in other populations in Africa [24].
Marked heterogeneity in syphilis and HSV-2 at the dis-
trict and state level can become apparent when comparing
burden of STIs across studies despite treatment policies
that often remain the same across geographic regions [25].
For example, syphilis seroprevalence in our study was
about four times that found in another study in a district
in the neighboring state Karnataka while HSV-2 in our
district level population was nearly 1/3 of that found in
the district in Karnataka [6]. HSV-2 and syphilis seropre-
valence rates were higher in urban areas and rates of
syphilis were higher in men than in women in our study,
while opposite trends were found in the Karnataka study.
However, testing algorithms and testing kits differed
between the two studies as well. While some of the differ-
ences in seroprevalence rates may be methodological, the
heterogeneous nature of the STI epidemic in India, could
explain the differences in findings at the district level, war-
ranting programmatic prevention and treatment programs
to reflect local conditions.
Our finding of a positive relationship between circum-
cised status and HSV-2 seroprevalence differs from the
inverse relationship between circumcision and HIV
Table 1 Population-based rates of HSV-2 and syphilis seroprevalence in Guntur District, Andhra Pradesh, South India
(N = 12,617).*
HSV-2
Men Women Total
Participants HSV
Positive
(%)
Adjusted
HSV
prevalence
%
95%
confidence
interval;
design effect
Participants HSV
Positive
(%)
Adjusted
HSV
prevalence
%
95%
confidence
interval;
design effect
Adjusted
HSV rate
%
95%
confidence
interval;
design effect
Rural 3139 120(3.82) 3.20 1.80-4.60; 4.30 3178 167(5.25) 4.56 2.55-6.57; 6.56 3.87 2.24-5.50; 9.88
Urban 3096 243(7.85) 8.15 6.03-10.27; 5.14 3204 417
(13.01)
12.77 9.78-15.76; 6.67 10.44 8.05-12.83;
10.08
Total 6235 363(5.82) 4.70 3.36-6.04; 5.40 6382 584(9.15) 7.07 5.06-9.08; 8.11 5.87 4.28-7.46; 12.08
Syphilis
Men Women Total
Participants Syphilis
Positive
(%)
Adjusted
syphilis
prevalence
%
95%
confidence
interval;
design effect
Participants Syphilis
Positive
(%)
Adjusted
syphilis
prevalence
%
95%
confidence
interval;
design effect
Adjusted
syphilis
rate %
95%
confidence
interval;
design effect
Rural 3139 55(1.75) 1.71 0.90-2.52; 3.01 3178 41(1.29) 1.38 0.90-1.86; 1.30 1.55 0.97-2.13; 3.38
Urban 3096 79(2.55) 2.93 2.05-3.81; 2.54 3204 45(1.40) 1.51 1.03-1.99; 1.57 2.22 1.61-2.83; 3.34
Total 6235 134(2.15) 2.08 1.48-2.68; 2.75 6382 86(1.35) 1.42 1.08-1.76; 1.41 1.75 1.33-2.17; 3.32
*Overall HSV-2 and syphilis seroprevalence adjusted for age, sex, gender and rural/urban distribution of the population in Guntur district.
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association with seroprevalent HSV-2 and syphilis in men.
Factor N (%
of
Total)
HSV-
2*
Syphilis
†
N( %
HSV-
2)
Odds of having
HSV-2 with
univariate analysis
(95% CI)
Adjusted odds of having
HSV-2 with multiple
logistic regression (95%
CI)
N( %
Syphilis)
Odds of having
syphilis with
univariate analysis
(95% CI)
Adjusted odds of having
syphilis with multiple
logistic regression (95%
CI)
Men (N = 6,235)
‡
Sociodemographics
Age (years)
15-19 1175
(18.8)
30
(2.6)
1.00 (ref) 1.00 (ref) 6 (0.5) 1.00 (ref)
20-24 1086
(17.4)
42
(3.9)
1.54 (0.95-2.47) 1.07 (0.62-1.84) 14 (1.3) 2.54 (0.97-6.65)
25-29 972
(15.6)
56
(5.8)
2.33 (1.49-3.67) 1.36 (0.77-2.40) 28 (2.9) 5.78 (2.38-14.01)
30-34 833
(13.4)
53
(6.4)
2.59 (1.64-4.10) 1.13 (0.62-2.06) 24 (2.9) 5.78 (2.35-14.20)
35-39 842
(13.5)
70
(8.3)
3.46 (2.23-5.36) 1.74 (0.97-3.11) 25 (3.0) 5.96 (2.43-14.60)
40-44 628
(10.1)
43
(6.8)
2.81 (1.74-4.52) 1.56 (0.84-2.88) 19 (3.0 6.08 (2.42-15.30)
45-49 699
(11.2)
69
(9.9)
4.18 (2.69-6.49) 2.60 (1.46-4.62) § 18 (2.6) 5.15 (2.03-13.04)
Standard of Living
Index ¶
0-16 1564
(25.1)
107
(6.8)
1.00 (ref) 1.00 (ref) 51 (3.3) 1.00 (ref)
17-22 1593
(25.5)
100
(6.3)
0.91 (0.69-1.21) 0.95 (0.69-1.29) 34 (2.1) 0.65 (0.42-1.0)
23-29 1529
(24.5)
89
(5.8)
0.84 (0.63-1.13) 0.95 (0.68-1.33) 23 (1.5) 0.45 (0.28-0.75)
30-54 1548
(24.8)
67
(4.3)
0.62 (0.45-0.84) 0.64 (0.43-0.95) § 26 (1.7) 0.51 (0.31-0.82)
Education
None 1573
(25.2)
103
(6.5)
1.00 (ref) 1.00 (ref) 47 (3.0) 1.00 (ref)
Class 1-10 3180
(51.0)
203
(6.4)
0.97 (0.76-1.24) 1.12 (0.85-1.49) 73 (2.3) 0.76 (0.53-1.11)
Class 11-12 518
(8.3)
24
(4.6)
0.69 (0.44-1.09) 1.18 (0.71-1.97) 3 (0.6) 0.19 (0.06-0.61)
More than
Class 12
960
(15.4)
33
(3.4)
0.51 (0.34-0.76) 0.82 (0.50-1.33) 11 (1.1) 0.38 (0.19-0.73)
Occupation
Other than
categories
below
4897
(78.5)
253
(5.2)
1.00 (ref) 86 (1.8) 1.00 (ref)
Transport
Related
438
(7.0)
39
(8.9)
1.79 (1.26-2.55) 24 (5.5) 3.24 (2.04-5.16) 2.18 (1.30-3.65)
Field Related 822
(13.2)
62
(7.5)
1.50 (1.12-2.0) 23 (2.8) 1.61 (1.01-2.57) 1.32 (0.81-2.17)
Begging/Sex
Work
18
(0.3)
5
(27.8)
7.06 (2.50-19.96) 0 (0) Model does not
converge
Model does not converge
Unemployed 60
(1.0)
4
(6.7)
1.31 (0.47-3.64) 1 (1.7) 0.95 (0.13-6.9) 0.74 (0.09-5.77)
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ciation with seroprevalent HSV-2 and syphilis in men. (Continued)
Caste
Forward 2,323
(37.3)
115
(5.0)
1.00 (ref) 36 (1.5) 1.00 (ref) 1.00 (ref)
Backward 1,532
(24.6)
98
(6.4)
1.31 (0.99-1.73) 47 (3.1) 2.01 (1.30-3.12) 1.66 (1.02-2.71) §
Scheduled 1285
(20.6)
80
(6.2)
1.27 (0.95-1.71) 27 (2.1) 1.36 (0.82-2.26) 1.01 (0.57-1.79)
Scheduled
Tribe
219
(3.5)
8
(3.7)
0.73 (0.35-1.51) 3 (1.4) 0.88 (0.27-2.89) 0.61 (0.18-2.13)
None 876
(14.0)
62
(7.1)
1.46 (1.06-2.01) 21 (2.4) 1.56 (0.91-2.69) 1.43 (0.79-2.59)
Place of Residence
Rural 3139
(50.3)
120
(3.8)
1.00 (ref) 1.00 (ref) 55 (1.8) 1.00 (ref)
Urban 3,096
(49.7)
243
(7.8)
2.14 (1.71-2.68) 2.21 (1.71-2.86) || 79 (2.6) 1.47 (1.04-2.08)
Health and Hygiene
History of Tattoo
No 5747
(92.2)
301
(5.2)
1.00 (ref) 1.00 (ref) 110 (1.9) 1.00 (ref)
Yes 483
(7.8)
62
(12.8)
2.66 (1.99-3.56) 1.66 (1.18-2.33) § 24 (5.0) 2.68 (1.71-4.21)
History of
Transfusion
No 6073
(97.5)
343
(5.6)
1.00 (ref) 130 (2.1) 1.00 (ref)
Yes 156
(2.5)
20
(12.8)
1.58 (1.20-2.07) 4 (2.6) 1.20 (0.44-3.30)
Circumcision
Uncircumcised 5156
(83.6)
278
(5.4)
1.00 (ref) 1.00 (ref) 107 (2.1)
Circumcised 1011
(16.4)
80
(7.9)
1.51 (1.16-1.95) 1.37 (1.03-1.82) § 25 (2.5) 1.20 (0.77-1.86)
Toilet Facility at
Home
Own Flush 1547
(24.8)
83
(5.4)
1.00 (ref) 21 (1.4) 1.00 (ref)
Share Flush/
Own Pit Toilet
1848
(29.6)
129
(7.0)
1.26 (1.01-1.57) 42 (2.3) 2.82 (1.34-5.90)
Share Pit
Toilet
307
(4.9)
17
(5.5)
0.90 (0.60-1.34) 11 (3.6) 1.85 (0.57-6.05)
None 2491
(40.0)
126
(5.1)
0.66 (0.52-0.83) 60 (2.4) 2.62 (1.27-5.43)
Chew or Smoke
Tobacco
Never 2722
(43.7)
111
(4.1)
1.00 (ref) 28 (1.0) 1.00 (ref) 1.00 (ref)
Previous 369
(5.9)
33
(8.9)
2.31 (1.54-3.46) 9 (2.4) 2.41 (1.13-5.14) 1.47 (0.65-3.34)
Current 3137
(50.3)
219
(7.0)
1.77 (1.40-2.23) 97 (3.1) 3.07 (2.01-4.69) 2.07 (1.26-3.41) §
Sexual Risk
Lifetime Female
Sex Partners
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Page 6 of 12found in Indian populations described previously [26],
and that of a randomized controlled trial [27]. More-
over, uncircumcised status demonstrated a strong posi-
tive association with HIV seroprevalence within this
same cohort in data described elsewhere [21]. A positive
association between HSV-2 and circumcision has also
been described in other epidemiologic work [28], and a
lack of association has also been reported [29]. Results
from a randomized controlled trial in Uganda, demon-
strate a protective effect of circumcision on HSV-2 [30],
however, potentially less protection than has been pre-
viously been found for HIV [27]. The role of sexual
partnering patterns at the population level may play a
significant role for HSV-2 acquisition, with cumulative
cases as an important HSV-2 risk factor. Observational
studies examining circumcision and STIs in India should
take into consideration potential sexual partnering dif-
ferences between circumcised and uncircumcised mem-
bers of the population, and residual confounding, which
may have resulted in the positive association of male
circumcision with HSV-2 seroprevalence in our cross-
sectional study.
We found lower odds of HSV-2 in women who
reported never using condom. The explanation could be
a higher frequency of condom use currently by those
who are at high risk of HSV-2 (risk compensation) and/
or a bias towards higher reporting of condom use by
those who are at higher risk of HIV/STI. We have pre-
viously reported a similar association between never
using condom and low HIV among both men and
women in this study [21].
This population level STI co-seroprevalence with HIV
data highlights and builds upon existing data from STI
clinics of high HIV/STI co-seroprevalence in India
[31,32]. Our finding that 23% of those seroprevalent for
syphilis and 12% seroprevalent for HSV-2, were also
found to be HIV infected has important implications for
STI syndromic management and HIV testing strategies
practiced in India. Because syndromic management is
not based on a proven diagnosis, such population based
Table 2: Combined multiple logistic regression model including socio-demographic and behavioral variables for asso-
ciation with seroprevalent HSV-2 and syphilis in men. (Continued)
0 1386
(22.5)
35
(2.5)
1.00 (ref) 1.00 (ref) 5 (0.4) 1.00 (ref) 1.00 (ref)
1 1671
(27.1)
73
(4.4)
1.62 (1.10-2.40) 1.23 (0.72-2.09) 33 (2.0) 4.19 (1.85-9.50) 2.96 (1.00-8.81)
2-3 1549
(25.1)
92
(5.9)
2.24 (1.54-3.28) 1.52 (0.89-2.61) 36 (2.3) 4.95 (2.19-11.15) 2.93 (0.97-8.83)
4-7 881
(14.1)
71
(8.8)
3.44 (2.31-5.12) 2.14 (1.22-3.76) § 32 (4.0) 8.60 (3.78-19.59) 4.50 (1.47-13.81) §
>7 672
(10.9)
87
(11.6)
4.68 (3.18-6.88) 2.44 (1.39-4.29) § 26 (3.5) 7.49 (3.23-17.33) 2.74 (0.86-8.73)
Sex with Men
Never 6029
(97.9)
338
(5.6)
1.00 (ref) 1.00 (ref) 127 (2.1) 1.00 (ref)
> 6 months
ago
85
(1.4)
9
(10.6)
1.99 (0.99-4.01) 1.27 (0.57-2.82) 2 (2.4) 1.12 (0.27-4.60)
Within last 6
months
47
(0.8)
11
(23.4)
5.14 (2.60-10.20) 2.95 (1.27-6.82) § 3 (6.4) 3.17 (0.97-10.34)
HIV/STI Serostatus
HIV 1/2 130
(2.1)
66
(51.6)
20.17 (14.03-28.99) 14.16 (9.37-21.40) || 29 (22.3) 16.41 (10.40-25.88) 8.70 (4.99-15.18) ||
HSV-2 363
(5.8)
- 33 (9.1) 5.71 (3.80-8.60) 2.35 (1.42-3.90) ||
Syphilis 134
(2.2)
33
(24.6)
5.71 (3.80-8.60) 2.08 (1.25-3.46) § -
*Variables included in final HSV-2 model: tatoo, circumcision, lifetime female sex partners, sex with men, HIV 1/2 serostatus, syphilis serostatus, age, SLI,
education, place of residence.
†Variables included in final syphilis model: chew or smoke tobacco, lifetime female sex partners, HIV 1/2 serostatus, HSV-2 serostatus, occupation, caste.
‡Data missing: 5 for tatoo, 6 for transfusion, 68 for circumcision, 7 for tobacco, 76 for female sex partners, 74 for sex with men, 1 for SLI, 4 for education and 265
for time away from home
Reflects number who responded to all items in table; the total for sub-categories may not add up to 12,617 due to some missing data.
§ p < 0.05 in final model
|| p < 0.001 in final model
¶Based on living conditions and assets, which was adapted from an index used previously by the National Health and Family Life Survey in India.[14]
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Page 7 of 12Table 3 Combined multiple logistic regression model including socio-demographic and behavioral variables for
association with seroprevalent HSV-2 and syphilis in women.
Factor N (%
of
Total)
HSV-
2*
Syphilis
†
N( %
HSV-
2)
Odds of having
HSV-2 with
univariate analysis
(95% CI)
Adjusted odds of having
HSV-2 with multiple
logistic regression (95%
CI)
N( %
Syphilis)
Odds of having
syphilis with
univariate analysis
(95% CI)
Adjusted odds of having
syphilis with multiple
logistic regression (95%
CI)
Women (N =
6,382) ‡
Sociodemographics
Age (years)
15-19 1,159
(18.2)
48
(4.1)
1.00 (ref) 1.00 (ref) 6 (0.5) 1.00 (ref) 1.00 (ref)
20-24 1,162
(18.2)
62
(5.3)
1.30 (0.89-1.92) 0.91 (0.58-1.44) 14 (1.2) 2.34 (0.90-6.12) 1.55 (0.54-4.45)
25-29 1,027
(16.1)
88
(8.6)
2.17 (1.51-3.12) 1.67 (1.07-2.61) § 9 (0.9) 1.70 (0.60-4.79) 0.85 (0.27-2.68)
30-34 886
(13.9)
110
(12.4)
3.28(2.31-4.66) 2.51 (1.61-3.90) || 19 (2.1) 4.21 (1.67-10.59) 1.88 (0.65-5.44)
35-39 864
(13.5)
118
(13.7)
3.66 (2.58-5.19) 3.13 (2.01-4.86) || 13 (1.5) 2.94 (1.11-7.75) 1.45 (0.49-4.33)
40-44 757
(11.9)
99
(13.1)
3.48 (2.43-4.98) 2.77 (1.76-4.39) || 19 (2.5) 4.95 (1.97-12.45) 2.90 (1.01-8.36) §
45-49 527
(8.3)
59
(11.2)
2.92 (1.96-4.34) 2.12 (1.29-3.51) § 6 (1.1) 2.21 (0.71-6.89) 1.39 (0.40-4.88)
Standard of Living
Index§
0-16 1,705
(26.7)
172
(10.1)
1.00 (ref) 1.00 (ref) 33 (1.9) 1.00 (ref)
17-22 1,603
(25.1)
154
(9.6)
0.95 (0.75-1.19) 0.87 (0.66-1.15) 25 (1.6) 0.80 (0.48-1.36)
23-29 1,522
(23.8)
144
(9.5)
0.93 (0.74-1.18) 0.93 (0.69-1.26) 16 (1.1) 0.54 (0.30-0.98)
30-54 1,552
(24.3)
114
(7.3)
0.71 (0.55-0.90) 0.61 (0.42-0.90) § 12 (0.8) 0.39 (0.20-0.77)
Education
None 2737
(42.9)
296
(10.8)
1.00 (ref) 48 (1.8) 1.00 (ref)
Class 1-10 2825
(44.3)
241
(8.5)
0.77 (0.64-0.92) 35 (1.2) 0.70 (0.45-1.09)
Class 11-12 335
(5.2)
20
(6.0)
0.52 (0.33-0.84) 3 (0.9) 0.51 (0.16-1.63)
More than
Class 12
484
(7.6)
27
(5.6)
0.52 (0.33-0.84) 0 (0.0) Model doesn’t
converge
Occupation
Other than
those below
5666
(88.8)
459
(8.1)
1.00 (ref) 73 (1.3) 1.00 (ref)
Field Related 92
(1.4)
15
(6.3)
2.21 (1.26-3.87) 4 (4.4) 3.53 (1.26-9.88)
Begging/Sex
Work
19
(0.3)
5
(26.3)
4.05 (1.45-11.30) 1 (5.3) 4.32 (0.57-32.8)
Unskilled
Labor
605
(9.5)
105
(17.4)
2.38 (1.89-3.0) 8 (1.4) 1.17 (0.58-2.36)
Caste
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Page 8 of 12Table 3: Combined multiple logistic regression model including socio-demographic and behavioral variables for asso-
ciation with seroprevalent HSV-2 and syphilis in women. (Continued)
Forward 2398
(37.6)
198
(8.3)
1.00 (ref) 1.00 (ref) 25 (1.0) 1.00 (ref)
Backward 1572
(24.6)
164
(10.4)
1.29 (1.04-1.61) 1.03 (0.80-1.33) 31 (2.0) 1.91 (1.12-3.25)
Scheduled 1315
(20.6)
125
(9.5)
1.17 (0.92-1.48) 1.29 (0.98-1.71) 18 (1.4) 1.32 (0.72-2.42)
Scheduled
Tribe
220
(3.4)
22
(10.0)
1.23 (0.78-1.96) 1.03 (0.61-1.73) 1 (0.5) 0.43 (0.06-3.21)
None 877
(13.7)
75
(8.6)
1.04 (0.79-1.37) 0.70 (0.51-0.96) § 11 (1.3) 1.21 (0.59-2.46)
Place of
Residence
Rural 3,178
(49.8)
167
(5.3)
1.00 (ref) 1.00 (ref) 41 (1.3) 1.00 (ref)
Urban 3,204
(50.2)
417
(13.0)
2.70 (2.24-3.25) 3.62 (2.76-4.76) || 45 (1.4) 1.09 (0.71-1.67)
Health and
Hygiene
History of
Transfusion
No 5,873
(92.0)
517
(8.8)
1.00 (ref) 81 (1.4) 1.00 (ref)
Yes 507
(7.9)
67
(13.2)
1.28 (0.95-1.72) 5 (1.0) 0.71 (0.29-1.77)
Toilet Facility at
Home
Own Flush 1,506
(23.7)
146
(9.7)
1.00 (ref) 9 (0.6) 1.00 (ref)
Share Flush/
Own Pit
Toilet
1,982
(31.1)
236
(11.9)
1.26 (1.01-1.57) 33 (1.7) 0.66 (0.52-0.83)
Share Pit
Toilet
363
(5.7)
32
(8.8)
0.90 (0.60-1.34) 4 (1.1) 1.85 (0.57-6.05)
None 2,512
(39.5)
166
(6.6)
0.66 (0.52-0.83) 39 (1.6) 2.62 (1.27-5.43)
Chew Tobacco
Never 6,305
(98.9)
566
(9.0)
1.00 (ref) 83 (1.3) 1.00 (ref)
Ever 67
(1.1)
17
(25.4)
1.77 (0.94-3.33) 2 (3.0) 2.31 (0.56-9.58)
Sexual Risk
Lifetime Male
Partners
0 759
(12.2)
30
(4.0)
1.00 (ref) 1.00 (ref) 2 (0.3) 1.00 (ref)
1 4,909
(78.9)
452
(9.2)
2.47 (1.69-3.60) 1.57 (0.91-2.73) 62 (1.3) 4.82 (1.18-19.76)
>1 551
(8.9)
88
(15.6)
4.68 (3.04-7.20) 2.61 (1.39-4.87) § 18 (3.3) 13.23 (3.06-57.26)
Condom Use
No sex in last
6 months
1449
(24.8)
143
(9.9)
1.00 (ref) 1.00 (ref) 17 (1.2) 1.00 (ref)
Sometimes/
Often Use
Condoms
124
(1.0)
21
(16.9)
1.86 (1.13-3.07) 1.12 (0.60-2.11) 4 (3.2) 2.81 (0.93-8.48)
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Page 9 of 12data is needed to inform local treatment algorithms. For
example in this district in Andhra Pradesh with poten-
tially less HSV-2, syndromic management that utilizes
less acyclovir therapy may be of higher priority than in
a neighboring state or district. Refinement of syndromic
management algorithms might include studies that
examine the etiology of genital ulceration and rates of
asymptomatic infection or viral shedding.
Furthermore, recent national guidelines for strength-
ening STI/RTI services within government institutions
[33] have lacked any mention of HIV testing at these
centers. In one recent study from an STI clinic in Pune
India, the majority of cases where both syphilis and HIV
were acquired were detected at the same follow up visit
suggesting co-transmission of HIV and syphilis [5]. Cur-
rent guidelines for the operational management of RTI/
STI clinics suggest that patients seeking STI care and
found to have an STI or with symptoms are to be
referred to local Integrated Counseling and Testing
Centers (ICTC) for HIV testing. However, evaluation of
the potential effectiveness of this approach has not been
done yet. While the numbers of ICTCs in Andhra Pra-
desh state has increased dramatically to 661 centers
[34], quality and accessibility has not been documented
publicly and barriers to seeking voluntary counseling
and testing have been reported [35]. Additions to gov-
ernment STI syndromic management algorithms could
include a longer duration and increased doses of penicil-
lin in HIV infected persons, for example. Additionally,
picking up acute or early HIV infection during this time
is critical to following through with partner notification
procedures. Improvements in sensitivity, specificity and
a decrease in the window period with newer rapid third
generation whole blood kits now commercially available
in parts of the country, suggest that HIV testing during
presentation with STI symptoms could be an ideal time
Table 3: Combined multiple logistic regression model including socio-demographic and behavioral variables for asso-
ciation with seroprevalent HSV-2 and syphilis in women. (Continued)
Never Use
Condoms
4,653
(74.7)
406
(8.7)
0.87 (0.71-1.07) 0.69 (0.53-0.91) § 61 (1.3) 1.12 (0.65-1.92)
HIV/STI serostatus
HIV 1/2 111
(1.7)
66
(59.5)
16.29 (11.03-24.04) 14.07 (8.84-22.40) || 21 (18.9) 22.28 (13.06-38.01) 8.19 (4.29-15.65) ||
HSV-2 584
(9.2)
- 44 (7.5) 11.17 (7.25-17.20) 6.33 (3.79-10.58) ||
Syphilis 86
(1.3)
44
(51.2)
11.17 (7.25-17.20) 6.66 (3.88-11.42) || -
*Variables included in final HSV-2 model: lifetime male partners, condom use, HIV 1/2 serostatus, syphilis serostatus, age, SLI, caste, place of residence.
†Variables included in final syphilis model: HIV 1/2 serostatus, HSV-2 serostatus, age
‡ Data missing for women: 2 for transfusion, 19 for toilet facility, 10 for chew tobacco, 163 for lifetime male partners, 156 for condom use, and 1 for education
Reflects number who responded to all items in table; the total for sub-categories may not add up to 12,617 due to some missing data.
§p < 0.05 in final model
|| p < 0.001 in final model
Based on living conditions and assets, which was adapted from an index used previously by the National Health and Family Life Survey in India.[14]
Table 4 Population-based gender rates of HSV-2/HIV and syphilis/HIV co-seroprevalence in Guntur District, Andhra
Pradesh, South India.*
HSV-2
Men Women Total
HSV
positive
HSV-2/HIV
co-
prevalence
Proportion of
HSV-2 co-
prevalence %
Adjusted
HSV-2/HIV
co-
prevalence
HSV-2
positive
HSV-HIV
co-
prevalence
Proportion
of HSV-2/
HIV
%
Adjusted
HSV-2/HIV
co-
prevalence
Proportion of
HSV-2 co-
prevalence %
Adjusted
co-
prevalence
%
Total 363 66 18.2 0.85 584 66 11.3 0.84 11.8 0.85
Syphilis
Men Women Total
Syphilis
positive
Syphilis/
HIV co-
prevalence
Proportion of
Syphilis co-
prevalence %
Adjusted
syphilis/HIV
co-
prevalence
Syphilis
positive
Syphilis-
HIV co-
prevalence
Proportion
of Syphilis/
HIV %
Adjusted
syphilis/HIV
co-
prevalence
Proportion of
Syphilis co-
prevalence %
Adjusted
co-
prevalence
%
Total 134 29 21.6 0.35 86 21 24.4 0.29 22.7 0.32
*Overall HSV-2/HIV and syphilis/HIV seroprevalence adjusted for age, sex, gender and rural/urban distribution of the population in Guntur district
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Page 10 of 12to pick up new cases of HIV and prevent loss to follow-
up of patients referred out for HIV testing.
There were several limitations of this study. The sam-
pling frame was limited to one district within Andhra
Pradesh and we are unable to extrapolate these findings
to other geographic regions. However, this information
is useful as it comes from a high HIV prevalent district
within a high HIV prevalent state and demonstrates
relatively low levels of HSV-2 and syphilis. Findings
from local data can impact our understanding of disease
at the national level as evidenced from the previously
described HIV prevalence from this study [15] which
played a major role in the downward estimation of HIV
burden for the country [36]. Additionally, without
further clinical history and non-specific syphilis testing,
we were unable to determine whether results from
syphilis IgG testing were consistent with active, incubat-
ing, treated or convalescent infection. However, the
yield of active syphilis would be less helpful from a
population-based study as active cases of syphilis would
be even less frequent in such a setting. Also high titers
would have been difficult to interpret without a clinical
history given that untreated secondary or tertiary syphi-
lis could be present, however, both conditions would be
insignificant in relation to transmission dynamics as
syphilis can be non-communicable after 1-4 years [16].
Herpes and syphilis suppression and control as HIV
prevention interventions have not been found to be
effective [7,8,37]. However, additional examination of
this HIV prevention strategy continues given the strong
relationship between these sexually transmitted infec-
tions and HIV. However, there may be specific situa-
tions where such control or suppression strategies are
used, such as during pregnancy, to prevent the devastat-
ing potential sequelae of neonatal herpes infection or
intrapartum syphilis infection. HSV-2 control may be
less important in this setting as an HIV prevention
strategy as the HIV epidemic has not spread widely and
levels of HSV-2 infection in India are relatively low.
Conclusion
T h i ss t u d yp r o v i d e sd a t ao nt h eb u r d e no fH S V - 2a n d
syphilis at the population level and its associations in a
high HIV prevalence part of India. The strong associa-
tion between HSV-2, syphilis and HIV seroprevalence in
this population-based study suggests that acceleration of
direct linkages between STI testing and HIV counseling
and testing would be useful in enhancing the control of
STIs and HIV in India.
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